CSL nelle notizie
Farmaci e vaccini biotecnologici
Tamtam ha trovato 13 articoli recenti su CSL.
- CSL shares: Buy, hold, or sell?
- Will CSL's Alentis Deal Reset Its Kidney Strategy (ASX:CSL)?
- CSL Limited (ASX:CSL): FY2026 Earnings Reflect Impairments and Biopharmaceutical Operations
- CSL vaccines unit slammed over UK compliance failures
- CSL vs CBA: Which ASX share is best for SMSFs?
- CSL to drop Terumo for Haemonetics in US plasma collection supply deal
- CSL Seqirus blasted for ‘multiple and prolonged deficiencies’
- Haemonetics shares jump as CSL sets 2027 rollout of plasma devices
- CSL (ASX:CSL) Backs Lixudebart As Investors Ask If The Undervalued View Still Holds
- CSL announces investment for share of Alentis rare kidney and liver candidate
- CSL Strikes New Deal as Shares Enjoy Rare Period Of Consolidation
- Australian Shares Flat; CSL Partners With Alentis Therapeutics to Develop Rare Kidney, Liver Disease Drug
- CSL signs deal with Trump administration to slash prices for its medicines
Articoli raccolti da Tamtam e conservati quando riguardano l'azienda, dal più recente. Ognuno rimanda alla sua fonte.
Vendi ad aziende come CSL?
Tamtam trova le aziende in linea con il tuo cliente ideale, analizza ogni account e ti dice chi contattare e quando.
Trova aziende simili